Resistance to Platinum-Containing Chemotherapy in Testicular Germ Cell Tumors Is Associated with Downregulation of the Protein Kinase SRPK1
Male germ cell tumors (GCTs) are extremely sensitive to platinum-containing chemotherapy, with only 10% of patients showing therapy resistance. However, the biological basis of the high curability of disseminated GCTs by chemotherapy is still unknown. Recently, we demonstrated that the mammalian ser...
Main Authors: | Paul W. Schenk, Hans Stoop, Carsten Bokemeyer, Frank Mayer, Gerrit Stoter, J. Wolter Oosterhuis, Erik Wiemer, Leendert H.J. Looijenga, Kees Nooter |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-07-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558604800770 |
Similar Items
-
Impaired expression of serine/arginine protein kinase 2 (SRPK2) affects melanoma progression
by: Mônica Maria Magalhães Caetano, et al.
Published: (2022-09-01) -
Good Cop, Bad Cop: The Different Roles of SRPKs
by: Eleni Nikolakaki, et al.
Published: (2022-06-01) -
Treatment of Germ Cell Testicular Cancer
by: Ana Koši Kunac, et al.
Published: (2020-01-01) -
SRPK2 Expression and Beta-Amyloid Accumulation Are Associated With BV2 Microglia Activation
by: Ziqi Tian, et al.
Published: (2022-01-01) -
PfSRPK1 Regulates Asexual Blood Stage Schizogony and Is Essential for Male Gamete Formation
by: Sudhir Kumar, et al.
Published: (2022-10-01)